Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciraparantag for Apixaban Reversal in Healthy Volunteers
NCT03288454Phase 2Completed
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciraparantag in anticoagulation reversal. Started Aug 2017; status: completed.
02
Drugs
ciraparantag
03
Conditions
anticoagulation reversal
Beyond the preview
Go deeper on NCT03288454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288454.